About 依度沙班 API

作用机制

Edoxaban is a direct oral anticoagulant (DOAC) that acts as a factor Xa inhibitor. It works by blocking the activity of factor Xa, a key component of the coagulation cascade.

Factor Xa plays a central role in the blood coagulation process, converting prothrombin to thrombin and leading to the formation of a blood clot. By inhibiting the activity of factor Xa, edoxaban helps to reduce the formation of blood clots and the risk of thromboembolic events such as stroke and deep vein thrombosis (DVT).

Edoxaban works differently from traditional anticoagulants such as warfarin, which work by blocking the recycling of vitamin K and the synthesis of coagulation factors. Unlike warfarin, edoxaban does not require frequent monitoring or dose adjustments and has a more predictable anticoagulant effect.

Overall, the mechanism of action of edoxaban involves the inhibition of factor Xa, leading to a reduction in the formation of blood clots and the risk of thromboembolic events.

适应症

Edoxaban is FDA-approved for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF). It is also indicated for the treatment and reduction of risk of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Atrial Fibrillation: Edoxaban is indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation who have one or more risk factors, such as age, congestive heart failure, hypertension, or previous stroke or transient ischemic attack (TIA).

Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE): Edoxaban is indicated for the treatment of DVT and PE, and for the reduction of the risk of recurrent DVT and PE following initial treatment with a parenteral anticoagulant.

Dr. Reddy's的专长

Dr. Reddy's总部位于印度海得拉巴，是全球领先的活性药物成分（API）供应商之一。 Dr. Reddy's的API业务是美国、欧洲、巴西、拉丁美洲、日本、中国、韩国和新兴市场的制药公司的首选合作伙伴。

Dr. Reddy's博士的API业务在过去30多年来在开发和制造复杂API（如类固醇，多肽，复杂长链分子和高效API（HPAPI /肿瘤药物））方面所建立的深厚技术优势中茁壮成长。 我们在知识产权和法规事务方面的实力可以帮助我们始终如一地达到并超越监管标准，从而为这一专业知识提供补充。 Dr. Reddy's博士 依度沙班 API是研发，知识产权和监管方面广泛专业知识的结果。

帮助我们的客户率先进入市场的关键组成部分是响应式供应链。 我们通过确保所有设施都高效运行并达到最新的质量，安全和生产率标准来实现这一目标。 业务和工厂之间的强大互联可以快速响应动态的市场变化，从而避免短缺并满足需求的突然激增。